rs183413880

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_181426.2(CCDC39):​c.1073C>T​(p.Thr358Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00495 in 1,539,912 control chromosomes in the GnomAD database, including 28 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T358A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0033 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0051 ( 26 hom. )

Consequence

CCDC39
NM_181426.2 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:11

Conservation

PhyloP100: 1.09

Publications

8 publications found
Variant links:
Genes affected
CCDC39 (HGNC:25244): (coiled-coil domain 39 molecular ruler complex subunit) The protein encoded by this gene is involved in the motility of cilia and flagella. The encoded protein is essential for the assembly of dynein regulatory and inner dynein arm complexes, which regulate ciliary beat. Defects in this gene are a cause of primary ciliary dyskinesia type 14 (CILD14). [provided by RefSeq, Jul 2011]
CCDC39 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 14
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009362876).
BP6
Variant 3-180651495-G-A is Benign according to our data. Variant chr3-180651495-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 166806.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0033 (502/152048) while in subpopulation NFE AF = 0.00488 (332/67968). AF 95% confidence interval is 0.00445. There are 2 homozygotes in GnomAd4. There are 238 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCDC39NM_181426.2 linkc.1073C>T p.Thr358Ile missense_variant Exon 9 of 20 ENST00000476379.6 NP_852091.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCDC39ENST00000476379.6 linkc.1073C>T p.Thr358Ile missense_variant Exon 9 of 20 2 NM_181426.2 ENSP00000417960.2

Frequencies

GnomAD3 genomes
AF:
0.00330
AC:
502
AN:
151930
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000895
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00315
Gnomad ASJ
AF:
0.0176
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00207
Gnomad FIN
AF:
0.000284
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00488
Gnomad OTH
AF:
0.00479
GnomAD2 exomes
AF:
0.00382
AC:
585
AN:
153056
AF XY:
0.00397
show subpopulations
Gnomad AFR exome
AF:
0.00108
Gnomad AMR exome
AF:
0.00241
Gnomad ASJ exome
AF:
0.0184
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000601
Gnomad NFE exome
AF:
0.00471
Gnomad OTH exome
AF:
0.00532
GnomAD4 exome
AF:
0.00513
AC:
7125
AN:
1387864
Hom.:
26
Cov.:
28
AF XY:
0.00513
AC XY:
3514
AN XY:
684612
show subpopulations
African (AFR)
AF:
0.000873
AC:
27
AN:
30914
American (AMR)
AF:
0.00277
AC:
95
AN:
34284
Ashkenazi Jewish (ASJ)
AF:
0.0173
AC:
433
AN:
25028
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35914
South Asian (SAS)
AF:
0.00232
AC:
177
AN:
76394
European-Finnish (FIN)
AF:
0.000471
AC:
23
AN:
48878
Middle Eastern (MID)
AF:
0.0104
AC:
59
AN:
5676
European-Non Finnish (NFE)
AF:
0.00555
AC:
5955
AN:
1073120
Other (OTH)
AF:
0.00617
AC:
356
AN:
57656
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
331
661
992
1322
1653
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
264
528
792
1056
1320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00330
AC:
502
AN:
152048
Hom.:
2
Cov.:
32
AF XY:
0.00320
AC XY:
238
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.000892
AC:
37
AN:
41462
American (AMR)
AF:
0.00314
AC:
48
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.0176
AC:
61
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00207
AC:
10
AN:
4822
European-Finnish (FIN)
AF:
0.000284
AC:
3
AN:
10570
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00488
AC:
332
AN:
67968
Other (OTH)
AF:
0.00474
AC:
10
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
28
55
83
110
138
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00456
Hom.:
8
Bravo
AF:
0.00352
TwinsUK
AF:
0.00566
AC:
21
ALSPAC
AF:
0.00701
AC:
27
ESP6500AA
AF:
0.000848
AC:
3
ESP6500EA
AF:
0.00472
AC:
38
ExAC
AF:
0.00157
AC:
170
Asia WGS
AF:
0.000289
AC:
1
AN:
3474

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:11
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:5
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CCDC39: BP4, BS2 -

Sep 14, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 31213628) -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Primary ciliary dyskinesia 14 Uncertain:1Benign:2
Nov 07, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

Sep 28, 2020
Johns Hopkins Genomics, Johns Hopkins University
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Aug 28, 2018
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia Benign:2
Aug 05, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.094
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.36
CADD
Benign
4.6
DANN
Benign
0.91
DEOGEN2
Benign
0.0087
T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.12
N
LIST_S2
Benign
0.48
T
M_CAP
Benign
0.025
T
MetaRNN
Benign
0.0094
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
0.0
N
PhyloP100
1.1
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-2.2
N
REVEL
Benign
0.25
Sift
Benign
0.055
T
Sift4G
Benign
0.15
T
Polyphen
0.22
B
Vest4
0.22
MVP
0.73
MPC
0.072
ClinPred
0.0099
T
GERP RS
-4.4
Varity_R
0.036
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.10
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs183413880; hg19: chr3-180369283; API